0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Interventional Oncology Ablation Device Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-9Z13187
Home | Market Reports | Health| Health Conditions| Cancer
Global Interventional Oncology Ablation Device Market Research Report 2023
BUY CHAPTERS

Global Interventional Oncology Ablation Device Market Research Report 2025

Code: QYRE-Auto-9Z13187
Report
July 2025
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Interventional Oncology Ablation Device Market Size

The global market for Interventional Oncology Ablation Device was valued at US$ 630 million in the year 2024 and is projected to reach a revised size of US$ 1106 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Interventional Oncology Ablation Device Market

Interventional Oncology Ablation Device Market

Tumor Ablation is a general term for destroying cancer cells. Interventional ablation is a targeted, image-guided therapy for liver, kidney and lung cancers that uses the direct application of extreme heat (radiofrequency and microwave) or cold (cryoablation) to destroy tumor cells. It is most appropriate for small kidney and liver cancers that cannot be removed surgically. In fact, radiofrequency and cryoablation of small kidney cancers have been shown to be just as effective as major surgery.
Increasing product approvals by regulatory authorities is expected to propel the growth of the global interventional oncology ablation market over the forecast period.
This report aims to provide a comprehensive presentation of the global market for Interventional Oncology Ablation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Oncology Ablation Device.
The Interventional Oncology Ablation Device market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Interventional Oncology Ablation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Oncology Ablation Device companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Interventional Oncology Ablation Device Market Report

Report Metric Details
Report Name Interventional Oncology Ablation Device Market
Accounted market size in year US$ 630 million
Forecasted market size in 2031 US$ 1106 million
CAGR 8.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boston Scientific, Medtronic, Johnson & Johnson, Merit Medical, Varian Medical, AngioDynamics, HealthTronics, EDAP TMS, SonaCare Medical, Misonix, CAScination AG, Biomedical Srl, Chongqing Haifu Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Interventional Oncology Ablation Device company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Interventional Oncology Ablation Device Market growing?

Ans: The Interventional Oncology Ablation Device Market witnessing a CAGR of 8.5% during the forecast period 2025-2031.

What is the Interventional Oncology Ablation Device Market size in 2031?

Ans: The Interventional Oncology Ablation Device Market size in 2031 will be US$ 1106 million.

Who are the main players in the Interventional Oncology Ablation Device Market report?

Ans: The main players in the Interventional Oncology Ablation Device Market are Boston Scientific, Medtronic, Johnson & Johnson, Merit Medical, Varian Medical, AngioDynamics, HealthTronics, EDAP TMS, SonaCare Medical, Misonix, CAScination AG, Biomedical Srl, Chongqing Haifu Medical

What are the Application segmentation covered in the Interventional Oncology Ablation Device Market report?

Ans: The Applications covered in the Interventional Oncology Ablation Device Market report are Liver Cancer, Lung Cancer, Kidney Cancer, Others

What are the Type segmentation covered in the Interventional Oncology Ablation Device Market report?

Ans: The Types covered in the Interventional Oncology Ablation Device Market report are Radiofrequency Ablation, Microwave Ablation, Cryoablation, Other

Recommended Reports

Ablation Device Markets

Tumor & Oncology Ablation

Catheter & System Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Oncology Ablation Device Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Radiofrequency Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Other
1.2.6 Radiofrequency Ablation
1.2.7 Microwave Ablation
1.2.8 Cryoablation
1.2.9 Other
1.3 Market by Application
1.3.1 Global Interventional Oncology Ablation Device Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.3.6 Liver Cancer
1.3.7 Lung Cancer
1.3.8 Kidney Cancer
1.3.9 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interventional Oncology Ablation Device Market Perspective (2020-2031)
2.2 Global Interventional Oncology Ablation Device Growth Trends by Region
2.2.1 Global Interventional Oncology Ablation Device Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Interventional Oncology Ablation Device Historic Market Size by Region (2020-2025)
2.2.3 Interventional Oncology Ablation Device Forecasted Market Size by Region (2026-2031)
2.3 Interventional Oncology Ablation Device Market Dynamics
2.3.1 Interventional Oncology Ablation Device Industry Trends
2.3.2 Interventional Oncology Ablation Device Market Drivers
2.3.3 Interventional Oncology Ablation Device Market Challenges
2.3.4 Interventional Oncology Ablation Device Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interventional Oncology Ablation Device Players by Revenue
3.1.1 Global Top Interventional Oncology Ablation Device Players by Revenue (2020-2025)
3.1.2 Global Interventional Oncology Ablation Device Revenue Market Share by Players (2020-2025)
3.2 Global Interventional Oncology Ablation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Interventional Oncology Ablation Device Revenue
3.4 Global Interventional Oncology Ablation Device Market Concentration Ratio
3.4.1 Global Interventional Oncology Ablation Device Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Oncology Ablation Device Revenue in 2024
3.5 Global Key Players of Interventional Oncology Ablation Device Head office and Area Served
3.6 Global Key Players of Interventional Oncology Ablation Device, Product and Application
3.7 Global Key Players of Interventional Oncology Ablation Device, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Oncology Ablation Device Breakdown Data by Type
4.1 Global Interventional Oncology Ablation Device Historic Market Size by Type (2020-2025)
4.2 Global Interventional Oncology Ablation Device Forecasted Market Size by Type (2026-2031)
5 Interventional Oncology Ablation Device Breakdown Data by Application
5.1 Global Interventional Oncology Ablation Device Historic Market Size by Application (2020-2025)
5.2 Global Interventional Oncology Ablation Device Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Interventional Oncology Ablation Device Market Size (2020-2031)
6.2 North America Interventional Oncology Ablation Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Interventional Oncology Ablation Device Market Size by Country (2020-2025)
6.4 North America Interventional Oncology Ablation Device Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interventional Oncology Ablation Device Market Size (2020-2031)
7.2 Europe Interventional Oncology Ablation Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Interventional Oncology Ablation Device Market Size by Country (2020-2025)
7.4 Europe Interventional Oncology Ablation Device Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interventional Oncology Ablation Device Market Size (2020-2031)
8.2 Asia-Pacific Interventional Oncology Ablation Device Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Interventional Oncology Ablation Device Market Size by Region (2020-2025)
8.4 Asia-Pacific Interventional Oncology Ablation Device Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Interventional Oncology Ablation Device Market Size (2020-2031)
9.2 Latin America Interventional Oncology Ablation Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Interventional Oncology Ablation Device Market Size by Country (2020-2025)
9.4 Latin America Interventional Oncology Ablation Device Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interventional Oncology Ablation Device Market Size (2020-2031)
10.2 Middle East & Africa Interventional Oncology Ablation Device Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Interventional Oncology Ablation Device Market Size by Country (2020-2025)
10.4 Middle East & Africa Interventional Oncology Ablation Device Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Details
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Interventional Oncology Ablation Device Introduction
11.1.4 Boston Scientific Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.1.5 Boston Scientific Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Interventional Oncology Ablation Device Introduction
11.2.4 Medtronic Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.2.5 Medtronic Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Interventional Oncology Ablation Device Introduction
11.3.4 Johnson & Johnson Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Merit Medical
11.4.1 Merit Medical Company Details
11.4.2 Merit Medical Business Overview
11.4.3 Merit Medical Interventional Oncology Ablation Device Introduction
11.4.4 Merit Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.4.5 Merit Medical Recent Development
11.5 Varian Medical
11.5.1 Varian Medical Company Details
11.5.2 Varian Medical Business Overview
11.5.3 Varian Medical Interventional Oncology Ablation Device Introduction
11.5.4 Varian Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.5.5 Varian Medical Recent Development
11.6 AngioDynamics
11.6.1 AngioDynamics Company Details
11.6.2 AngioDynamics Business Overview
11.6.3 AngioDynamics Interventional Oncology Ablation Device Introduction
11.6.4 AngioDynamics Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.6.5 AngioDynamics Recent Development
11.7 HealthTronics
11.7.1 HealthTronics Company Details
11.7.2 HealthTronics Business Overview
11.7.3 HealthTronics Interventional Oncology Ablation Device Introduction
11.7.4 HealthTronics Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.7.5 HealthTronics Recent Development
11.8 EDAP TMS
11.8.1 EDAP TMS Company Details
11.8.2 EDAP TMS Business Overview
11.8.3 EDAP TMS Interventional Oncology Ablation Device Introduction
11.8.4 EDAP TMS Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.8.5 EDAP TMS Recent Development
11.9 SonaCare Medical
11.9.1 SonaCare Medical Company Details
11.9.2 SonaCare Medical Business Overview
11.9.3 SonaCare Medical Interventional Oncology Ablation Device Introduction
11.9.4 SonaCare Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.9.5 SonaCare Medical Recent Development
11.10 Misonix
11.10.1 Misonix Company Details
11.10.2 Misonix Business Overview
11.10.3 Misonix Interventional Oncology Ablation Device Introduction
11.10.4 Misonix Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.10.5 Misonix Recent Development
11.11 CAScination AG
11.11.1 CAScination AG Company Details
11.11.2 CAScination AG Business Overview
11.11.3 CAScination AG Interventional Oncology Ablation Device Introduction
11.11.4 CAScination AG Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.11.5 CAScination AG Recent Development
11.12 Biomedical Srl
11.12.1 Biomedical Srl Company Details
11.12.2 Biomedical Srl Business Overview
11.12.3 Biomedical Srl Interventional Oncology Ablation Device Introduction
11.12.4 Biomedical Srl Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.12.5 Biomedical Srl Recent Development
11.13 Chongqing Haifu Medical
11.13.1 Chongqing Haifu Medical Company Details
11.13.2 Chongqing Haifu Medical Business Overview
11.13.3 Chongqing Haifu Medical Interventional Oncology Ablation Device Introduction
11.13.4 Chongqing Haifu Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.13.5 Chongqing Haifu Medical Recent Development
11.14 Boston Scientific
11.14.1 Boston Scientific Company Details
11.14.2 Boston Scientific Business Overview
11.14.3 Boston Scientific Interventional Oncology Ablation Device Introduction
11.14.4 Boston Scientific Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.14.5 Boston Scientific Recent Development
11.15 Medtronic
11.15.1 Medtronic Company Details
11.15.2 Medtronic Business Overview
11.15.3 Medtronic Interventional Oncology Ablation Device Introduction
11.15.4 Medtronic Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.15.5 Medtronic Recent Development
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Company Details
11.16.2 Johnson & Johnson Business Overview
11.16.3 Johnson & Johnson Interventional Oncology Ablation Device Introduction
11.16.4 Johnson & Johnson Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.16.5 Johnson & Johnson Recent Development
11.17 Merit Medical
11.17.1 Merit Medical Company Details
11.17.2 Merit Medical Business Overview
11.17.3 Merit Medical Interventional Oncology Ablation Device Introduction
11.17.4 Merit Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.17.5 Merit Medical Recent Development
11.18 Varian Medical
11.18.1 Varian Medical Company Details
11.18.2 Varian Medical Business Overview
11.18.3 Varian Medical Interventional Oncology Ablation Device Introduction
11.18.4 Varian Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.18.5 Varian Medical Recent Development
11.19 AngioDynamics
11.19.1 AngioDynamics Company Details
11.19.2 AngioDynamics Business Overview
11.19.3 AngioDynamics Interventional Oncology Ablation Device Introduction
11.19.4 AngioDynamics Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.19.5 AngioDynamics Recent Development
11.20 HealthTronics
11.20.1 HealthTronics Company Details
11.20.2 HealthTronics Business Overview
11.20.3 HealthTronics Interventional Oncology Ablation Device Introduction
11.20.4 HealthTronics Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.20.5 HealthTronics Recent Development
11.21 EDAP TMS
11.21.1 EDAP TMS Company Details
11.21.2 EDAP TMS Business Overview
11.21.3 EDAP TMS Interventional Oncology Ablation Device Introduction
11.21.4 EDAP TMS Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.21.5 EDAP TMS Recent Development
11.22 SonaCare Medical
11.22.1 SonaCare Medical Company Details
11.22.2 SonaCare Medical Business Overview
11.22.3 SonaCare Medical Interventional Oncology Ablation Device Introduction
11.22.4 SonaCare Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.22.5 SonaCare Medical Recent Development
11.23 Misonix
11.23.1 Misonix Company Details
11.23.2 Misonix Business Overview
11.23.3 Misonix Interventional Oncology Ablation Device Introduction
11.23.4 Misonix Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.23.5 Misonix Recent Development
11.24 CAScination AG
11.24.1 CAScination AG Company Details
11.24.2 CAScination AG Business Overview
11.24.3 CAScination AG Interventional Oncology Ablation Device Introduction
11.24.4 CAScination AG Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.24.5 CAScination AG Recent Development
11.25 Biomedical Srl
11.25.1 Biomedical Srl Company Details
11.25.2 Biomedical Srl Business Overview
11.25.3 Biomedical Srl Interventional Oncology Ablation Device Introduction
11.25.4 Biomedical Srl Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.25.5 Biomedical Srl Recent Development
11.26 Chongqing Haifu Medical
11.26.1 Chongqing Haifu Medical Company Details
11.26.2 Chongqing Haifu Medical Business Overview
11.26.3 Chongqing Haifu Medical Interventional Oncology Ablation Device Introduction
11.26.4 Chongqing Haifu Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025)
11.26.5 Chongqing Haifu Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Interventional Oncology Ablation Device Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Radiofrequency Ablation
 Table 3. Key Players of Microwave Ablation
 Table 4. Key Players of Cryoablation
 Table 5. Key Players of Other
 Table 6. Key Players of Radiofrequency Ablation
 Table 7. Key Players of Microwave Ablation
 Table 8. Key Players of Cryoablation
 Table 9. Global Interventional Oncology Ablation Device Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Interventional Oncology Ablation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Interventional Oncology Ablation Device Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Interventional Oncology Ablation Device Market Share by Region (2020-2025)
 Table 13. Global Interventional Oncology Ablation Device Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Interventional Oncology Ablation Device Market Share by Region (2026-2031)
 Table 15. Interventional Oncology Ablation Device Market Trends
 Table 16. Interventional Oncology Ablation Device Market Drivers
 Table 17. Interventional Oncology Ablation Device Market Challenges
 Table 18. Interventional Oncology Ablation Device Market Restraints
 Table 19. Global Interventional Oncology Ablation Device Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Interventional Oncology Ablation Device Market Share by Players (2020-2025)
 Table 21. Global Top Interventional Oncology Ablation Device Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Oncology Ablation Device as of 2024)
 Table 22. Ranking of Global Top Interventional Oncology Ablation Device Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Interventional Oncology Ablation Device Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Interventional Oncology Ablation Device, Headquarters and Area Served
 Table 25. Global Key Players of Interventional Oncology Ablation Device, Product and Application
 Table 26. Global Key Players of Interventional Oncology Ablation Device, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Interventional Oncology Ablation Device Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Interventional Oncology Ablation Device Revenue Market Share by Type (2020-2025)
 Table 30. Global Interventional Oncology Ablation Device Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Interventional Oncology Ablation Device Revenue Market Share by Type (2026-2031)
 Table 32. Global Interventional Oncology Ablation Device Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Interventional Oncology Ablation Device Revenue Market Share by Application (2020-2025)
 Table 34. Global Interventional Oncology Ablation Device Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Interventional Oncology Ablation Device Revenue Market Share by Application (2026-2031)
 Table 36. North America Interventional Oncology Ablation Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Interventional Oncology Ablation Device Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Interventional Oncology Ablation Device Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Interventional Oncology Ablation Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Interventional Oncology Ablation Device Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Interventional Oncology Ablation Device Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Interventional Oncology Ablation Device Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Interventional Oncology Ablation Device Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Interventional Oncology Ablation Device Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Interventional Oncology Ablation Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Interventional Oncology Ablation Device Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Interventional Oncology Ablation Device Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Interventional Oncology Ablation Device Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Interventional Oncology Ablation Device Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Interventional Oncology Ablation Device Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Boston Scientific Company Details
 Table 52. Boston Scientific Business Overview
 Table 53. Boston Scientific Interventional Oncology Ablation Device Product
 Table 54. Boston Scientific Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 55. Boston Scientific Recent Development
 Table 56. Medtronic Company Details
 Table 57. Medtronic Business Overview
 Table 58. Medtronic Interventional Oncology Ablation Device Product
 Table 59. Medtronic Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 60. Medtronic Recent Development
 Table 61. Johnson & Johnson Company Details
 Table 62. Johnson & Johnson Business Overview
 Table 63. Johnson & Johnson Interventional Oncology Ablation Device Product
 Table 64. Johnson & Johnson Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 65. Johnson & Johnson Recent Development
 Table 66. Merit Medical Company Details
 Table 67. Merit Medical Business Overview
 Table 68. Merit Medical Interventional Oncology Ablation Device Product
 Table 69. Merit Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 70. Merit Medical Recent Development
 Table 71. Varian Medical Company Details
 Table 72. Varian Medical Business Overview
 Table 73. Varian Medical Interventional Oncology Ablation Device Product
 Table 74. Varian Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 75. Varian Medical Recent Development
 Table 76. AngioDynamics Company Details
 Table 77. AngioDynamics Business Overview
 Table 78. AngioDynamics Interventional Oncology Ablation Device Product
 Table 79. AngioDynamics Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 80. AngioDynamics Recent Development
 Table 81. HealthTronics Company Details
 Table 82. HealthTronics Business Overview
 Table 83. HealthTronics Interventional Oncology Ablation Device Product
 Table 84. HealthTronics Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 85. HealthTronics Recent Development
 Table 86. EDAP TMS Company Details
 Table 87. EDAP TMS Business Overview
 Table 88. EDAP TMS Interventional Oncology Ablation Device Product
 Table 89. EDAP TMS Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 90. EDAP TMS Recent Development
 Table 91. SonaCare Medical Company Details
 Table 92. SonaCare Medical Business Overview
 Table 93. SonaCare Medical Interventional Oncology Ablation Device Product
 Table 94. SonaCare Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 95. SonaCare Medical Recent Development
 Table 96. Misonix Company Details
 Table 97. Misonix Business Overview
 Table 98. Misonix Interventional Oncology Ablation Device Product
 Table 99. Misonix Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 100. Misonix Recent Development
 Table 101. CAScination AG Company Details
 Table 102. CAScination AG Business Overview
 Table 103. CAScination AG Interventional Oncology Ablation Device Product
 Table 104. CAScination AG Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 105. CAScination AG Recent Development
 Table 106. Biomedical Srl Company Details
 Table 107. Biomedical Srl Business Overview
 Table 108. Biomedical Srl Interventional Oncology Ablation Device Product
 Table 109. Biomedical Srl Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 110. Biomedical Srl Recent Development
 Table 111. Chongqing Haifu Medical Company Details
 Table 112. Chongqing Haifu Medical Business Overview
 Table 113. Chongqing Haifu Medical Interventional Oncology Ablation Device Product
 Table 114. Chongqing Haifu Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 115. Chongqing Haifu Medical Recent Development
 Table 116. Boston Scientific Company Details
 Table 117. Boston Scientific Business Overview
 Table 118. Boston Scientific Interventional Oncology Ablation Device Product
 Table 119. Boston Scientific Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 120. Boston Scientific Recent Development
 Table 121. Medtronic Company Details
 Table 122. Medtronic Business Overview
 Table 123. Medtronic Interventional Oncology Ablation Device Product
 Table 124. Medtronic Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 125. Medtronic Recent Development
 Table 126. Johnson & Johnson Company Details
 Table 127. Johnson & Johnson Business Overview
 Table 128. Johnson & Johnson Interventional Oncology Ablation Device Product
 Table 129. Johnson & Johnson Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 130. Johnson & Johnson Recent Development
 Table 131. Merit Medical Company Details
 Table 132. Merit Medical Business Overview
 Table 133. Merit Medical Interventional Oncology Ablation Device Product
 Table 134. Merit Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 135. Merit Medical Recent Development
 Table 136. Varian Medical Company Details
 Table 137. Varian Medical Business Overview
 Table 138. Varian Medical Interventional Oncology Ablation Device Product
 Table 139. Varian Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 140. Varian Medical Recent Development
 Table 141. AngioDynamics Company Details
 Table 142. AngioDynamics Business Overview
 Table 143. AngioDynamics Interventional Oncology Ablation Device Product
 Table 144. AngioDynamics Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 145. AngioDynamics Recent Development
 Table 146. HealthTronics Company Details
 Table 147. HealthTronics Business Overview
 Table 148. HealthTronics Interventional Oncology Ablation Device Product
 Table 149. HealthTronics Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 150. HealthTronics Recent Development
 Table 151. EDAP TMS Company Details
 Table 152. EDAP TMS Business Overview
 Table 153. EDAP TMS Interventional Oncology Ablation Device Product
 Table 154. EDAP TMS Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 155. EDAP TMS Recent Development
 Table 156. SonaCare Medical Company Details
 Table 157. SonaCare Medical Business Overview
 Table 158. SonaCare Medical Interventional Oncology Ablation Device Product
 Table 159. SonaCare Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 160. SonaCare Medical Recent Development
 Table 161. Misonix Company Details
 Table 162. Misonix Business Overview
 Table 163. Misonix Interventional Oncology Ablation Device Product
 Table 164. Misonix Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 165. Misonix Recent Development
 Table 166. CAScination AG Company Details
 Table 167. CAScination AG Business Overview
 Table 168. CAScination AG Interventional Oncology Ablation Device Product
 Table 169. CAScination AG Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 170. CAScination AG Recent Development
 Table 171. Biomedical Srl Company Details
 Table 172. Biomedical Srl Business Overview
 Table 173. Biomedical Srl Interventional Oncology Ablation Device Product
 Table 174. Biomedical Srl Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 175. Biomedical Srl Recent Development
 Table 176. Chongqing Haifu Medical Company Details
 Table 177. Chongqing Haifu Medical Business Overview
 Table 178. Chongqing Haifu Medical Interventional Oncology Ablation Device Product
 Table 179. Chongqing Haifu Medical Revenue in Interventional Oncology Ablation Device Business (2020-2025) & (US$ Million)
 Table 180. Chongqing Haifu Medical Recent Development
 Table 181. Research Programs/Design for This Report
 Table 182. Key Data Information from Secondary Sources
 Table 183. Key Data Information from Primary Sources
 Table 184. Authors List of This Report


List of Figures
 Figure 1. Interventional Oncology Ablation Device Picture
 Figure 2. Global Interventional Oncology Ablation Device Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Interventional Oncology Ablation Device Market Share by Type: 2024 VS 2031
 Figure 4. Radiofrequency Ablation Features
 Figure 5. Microwave Ablation Features
 Figure 6. Cryoablation Features
 Figure 7. Other Features
 Figure 8. Radiofrequency Ablation Features
 Figure 9. Microwave Ablation Features
 Figure 10. Cryoablation Features
 Figure 11. Other Features
 Figure 12. Global Interventional Oncology Ablation Device Market Size by Application (2020-2031) & (US$ Million)
 Figure 13. Global Interventional Oncology Ablation Device Market Share by Application: 2024 VS 2031
 Figure 14. Liver Cancer Case Studies
 Figure 15. Lung Cancer Case Studies
 Figure 16. Kidney Cancer Case Studies
 Figure 17. Others Case Studies
 Figure 18. Liver Cancer Case Studies
 Figure 19. Lung Cancer Case Studies
 Figure 20. Kidney Cancer Case Studies
 Figure 21. Others Case Studies
 Figure 22. Interventional Oncology Ablation Device Report Years Considered
 Figure 23. Global Interventional Oncology Ablation Device Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 24. Global Interventional Oncology Ablation Device Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 25. Global Interventional Oncology Ablation Device Market Share by Region: 2024 VS 2031
 Figure 26. Global Interventional Oncology Ablation Device Market Share by Players in 2024
 Figure 27. Global Top Interventional Oncology Ablation Device Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Oncology Ablation Device as of 2024)
 Figure 28. The Top 10 and 5 Players Market Share by Interventional Oncology Ablation Device Revenue in 2024
 Figure 29. North America Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. North America Interventional Oncology Ablation Device Market Share by Country (2020-2031)
 Figure 31. United States Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Canada Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Europe Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Europe Interventional Oncology Ablation Device Market Share by Country (2020-2031)
 Figure 35. Germany Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. France Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. U.K. Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Italy Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Russia Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Nordic Countries Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Asia-Pacific Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Interventional Oncology Ablation Device Market Share by Region (2020-2031)
 Figure 43. China Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Japan Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. South Korea Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Southeast Asia Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. India Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Australia Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Latin America Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Latin America Interventional Oncology Ablation Device Market Share by Country (2020-2031)
 Figure 51. Mexico Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Brazil Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Middle East & Africa Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Middle East & Africa Interventional Oncology Ablation Device Market Share by Country (2020-2031)
 Figure 55. Turkey Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 57. UAE Interventional Oncology Ablation Device Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 58. Boston Scientific Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 59. Medtronic Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 60. Johnson & Johnson Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 61. Merit Medical Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 62. Varian Medical Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 63. AngioDynamics Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 64. HealthTronics Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 65. EDAP TMS Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 66. SonaCare Medical Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 67. Misonix Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 68. CAScination AG Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 69. Biomedical Srl Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 70. Chongqing Haifu Medical Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 71. Boston Scientific Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 72. Medtronic Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 73. Johnson & Johnson Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 74. Merit Medical Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 75. Varian Medical Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 76. AngioDynamics Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 77. HealthTronics Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 78. EDAP TMS Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 79. SonaCare Medical Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 80. Misonix Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 81. CAScination AG Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 82. Biomedical Srl Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 83. Chongqing Haifu Medical Revenue Growth Rate in Interventional Oncology Ablation Device Business (2020-2025)
 Figure 84. Bottom-up and Top-down Approaches for This Report
 Figure 85. Data Triangulation
 Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart